Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model.
about
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial.Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging
P2860
Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Mucolytic Agents Can Enhance H ...... Cancer Xenograft Mouse Model.
@en
type
label
Mucolytic Agents Can Enhance H ...... Cancer Xenograft Mouse Model.
@en
prefLabel
Mucolytic Agents Can Enhance H ...... Cancer Xenograft Mouse Model.
@en
P2093
P2860
P1476
Mucolytic Agents Can Enhance H ...... Cancer Xenograft Mouse Model.
@en
P2093
B Vanderlinden
G Van Simaeys
R Morandini
P2860
P2888
P304
P356
10.1007/S11307-015-0840-X
P577
2015-03-12T00:00:00Z